A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer
Clinical trial NCT04506554 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04506554
- Sponsor
- Fox Chase Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2026-05-01
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.